Human immunodeficiency virus and the gastrointestinal immune system: Does highly active antiretroviral therapy restore gut immunity

Mucosal Immunology

Volumn 5, Issue 6, 2012, Pages 596-604

  Costiniuk, C T ^a,b   Angel, J B ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867955049     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.82     Document Type: Review

References (67)

1. Chun, T. W. et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714-720 (2009).
2. Yukl, S. et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J. Infect. Dis. 202, 1553-1561 (2010).
3. Hofer, U. & Speck, R. F. Disturbance of gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin. Immunopathol. 31, 257-266 (2009).
4. Brenchley, J. M. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 749-759 (2004). (Pubitemid 39299461)
5. Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites. J. Exp. Med. 200 , 761-770 (2004). (Pubitemid 39299462)
6. Mattapallil, J. J. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434, 1093-1097 (2005). (Pubitemid 40663481)
7. Cheroutre, H. & Madakamutil, L. Acquired and natural memory T cells joining forces at the mucosal front line. Nat. Rev. Immunol. 4, 292-300 (2004).
8. Husband, A. J. & Gowans, J. L. The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J. Exp. Med. 148 , 1146-1160 (1978). (Pubitemid 9053635)
9. Mehandru, S. The gastrointestinal tract in HIV-1: Questions, Answers, and More Questions. Available at http://www.prn.org/index/php/progression/article/ hiv-1-gastrointestinal-galt-267, accessed 24 February 2012).
10. Kotler, D. P. et al. Enteropathy associated with the acquired immunodefi ciency syndrome. Ann. Intern. Med. 101, 421-428 (1984). (Pubitemid 14018034)
11. Ullrich, R., Zeitz, M. & Riecken, E. O. Enteric immunologic abnormalities in human immunodefi ciency virus infection. Semin. Liver Dis. 12, 167-174 (1992).
12. Sankaran, S. et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodefi ciency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82, 538-545 (2008). (Pubitemid 350309168)
13. Dandekar, S. Pathogenesis of HIV in the gastrointestinal tract. Curr. HIV AIDS Rep. 4, 10-15 (2007). (Pubitemid 46555246)
14. George, M. D., Reay, E., Sankaran, S. & Dandekar, S. Early antiretroviral therapy for simian immunodefi ciency virus infection leads to mucosal CD4+ T cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J. Virol. 79, 2709-2729 (2005).
15. Sankaran, S. et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 102, 9860-9856 (2005).
16. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2008).
17. Acunata, P. et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3, e2516. doi:10.1371/journal.pone.0002516 (2008).
18. Guadalupe, M. et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodefi ciency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003). (Pubitemid 37271669)
19. Chege, D. et al. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS 25, 741-749 (2010).
20. Guadalupe, M. et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodefi ciency virus type-1 infected patients initiating therapy during primary or chronic infection. J. Virol. 80 , 8236-8247 (2006). (Pubitemid 44182323)
21. Mehandru, S. et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 3 , e484 (2006).
22. Mowat, A. & Viney, J. The anatomical basis of intestinal immunity. Immunol. Rev. 156, 145-166 (1997). (Pubitemid 27197200)
23. Kotler, D. P. et al. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS 12 , 597-604 (1998). (Pubitemid 28162098)
24. Talal, A. H. et al. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue. J. Acquir. Immune Defi c. Syndr. 26, 1-7 (2001). (Pubitemid 32115045)
25. Sheth, P. M. et al. Immune reconstitution in the sigmoid colon after longterm HIV therapy. Mucosal Immunol. 1, 382-388 (2008).
26. Macal, M. et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specifi c T-cell responses. Mucosal Immunol. 1, 475-488 (2008).
27. Chege, D. et al. Effect of raltegravir intensifi cation on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized control trial. AIDS 26, 167-174 (2012).
28. Kovacs, J. A. et al. Controlled trial of interleukin-2 infusions on patients infected with the human immunodefi ciency virus. N. Engl. J. Med. 335 , 1350-1356 (1996). (Pubitemid 26360453)
29. Read, S. W. et al. The effect of intermittent IL-2 therapy on CD4T cells in the gut in HIV-1-infected patients. J. Acquir. Immune Defi c. Syndr. 56 , 340-343 (2006).
30. Dandekar, S., George, M. D. & Baumler, A. J. Th17 cells, HIV and the gut mucosal barrier. Curr. Opin. HIV AIDS 5, 173-178 (2010).
31. Epple, H. J. et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108, 3072-3078 (2006).
32. Kanwar, B., Favre, D. & McCune, J. M. Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr. Opin. HIV AIDS 5, 151-157 (2010).
33. Ciccone, E. J. et al. Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol. 3, 172-181 (2010).
34. Mavigner, M. et al. Altered CD4+ T cell homing to the gut impairs mucosal reconstitution in treated HIV-infected individuals. J. Clin. Invest. 122 , 62-69 (2012).
35. Krzysiek, R. et al. Preferential and persistent depletion of CCD5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection. Blood 98, 3169-3171 (2001).
36. Liu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R. & Giorgi , J. V. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defi c. Syndr. Hum. Retrovirol. 16, 83-92 (1997).
37. Schacklett, B. L., Cox, C. A., Sandberg, J. K., Stollman, N. H., Jacobson , M. A. & Nixon, D. F. Traffi cking of human immunodefi ciency virus type 1-specifi c CD8+ T cells to gut-associated lymphoid tissue during chronic infection. J. Virol. 77, 5621-5631 (2003). (Pubitemid 36538954)
38. Critchfi eld, J. W. et al. Multifunctional human immunodefi ciency virus (HIV) Gag-specifi c CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J. Virol. 81 , 5460-5471 (2007).
39. Critchfi eld, J. W. et al. Magnitude and complexity of rectal mucosa HIV-1-specifi c CD8+ T cell responses during chronic infection refl ect clinical status. PLoS ONE 3, e3577 (2008).
40. Lerner, P. et al. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy. J. Virol. 85, 4774-4782 (2011).
41. Alter, G. et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 195, 1452-1460 (2007). (Pubitemid 46717463)
42. Sips, M. et al. Altered distribution of mucosal NK cells during HIV infection. Mucosal Immunol. 5, 30-40 (2012).
43. Mela, C. M. et al. Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals. AIDS 21, 217-2182 (2007).
44. Bukowski, J. F., Morita, C. T. & Brenner, M. B. Human gamma delta T cells recognize alkylamines derived microbes, edible plants, and tea: implications for innate immunity. Immunity. 11, 57-65 (1999). (Pubitemid 29359957)
45. Kagnoff, M. F. Current concepts in mucosal immunity. III Ontogeny and function of gamma delta T cells in the intestine. Am. J. Physiol. 274 , G455-G458 (1998).
46. Shibata, K., Yamada, H., Hara, H., Kishihara, K. & Yoshikai, Y. Resident Vdelta1+ gammadelta T cells control early infi ltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178 , 4466-4472 (2007). (Pubitemid 46492398)
47. Harris, L. D. et al. Mechanisms underlying T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 116, 4148-4157 (2010).
48. Nilssen, D. E. et al. Intraepithelial/T cells in duodenal mucosa are related to the immune state and survival time in AIDS. J. Virol. 70 , 3545-3550 (1996). (Pubitemid 26157334)
49. Nilssen, D. E. & Brandtzaeg, P. Intraepithelial/T cells remain increased in the duodenum of AIDS patients despite antiretroviral treatment. PLoS ONE 7, e29066 (2012).
50. Eriksson, K., Hagberg, L., Norkrans, G., Holmgren, J. & Czerkinsky, C. Virus-specifi c antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. AIDS 9, 695-700 (1995).
51. Levesque, M. C. et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med. 6, e1000107 (2009).
52. Nilssen, D. E. et al. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut 53, 487-493 (2003).
53. Batman, P. A. et al. HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda. Gut 43, 350-355 (1998). (Pubitemid 28414916)
54. Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodefi ciency virus infections. PLoS Pathog. 6, e1001052 (2010).
55. Epple, H. J. et al. Impairment of the intestinal barrier is evidence in untreated but absent in suppressively treated HIV-infected patients. Gut 58, 220-227 (2009).
56. Smith, A. J., Schacker, T. W., Reilly, C. S. & Haase, A. T. A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. J. Acquir. Immune Defi c. Syndr. 55, 306-315 (2010).
57. Ellis, C. L. et al. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantifi cation and correlations with immune activation. J. Acquir. Immune Defi c. Syndr. 57, 363-370 (2011).
58. Cassol, E. et al. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J. Infect. Dis. 202, 723-733 (2010).
59. Jiang, W. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177-1185 (2009).
60. d 'Ettore, G. et al. HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS. Curr. HIV Res. 9, 148-153 (2011).
61. Baroncelli, S. et al. Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with 50 copies/ml HIV-1 RNA. J. Clin. Virol. 46, 367-370 (2009).
62. Schacker, T. W. et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J. Clin. Invest. 110, 1133-1139 (2002). (Pubitemid 35215894)
63. Schacker, T. et al. Persistent abnormalities in lymphoid tissues in human immunodefi ciency virus-infected patients successfully treated with highly active antitretroviral therapy. J. Infect. Dis. 186, 1092-1097 (2002). (Pubitemid 35177111)
64. Estes, J. D., Haase, A. T. & Schacker, T. W. The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. Semin. Immunol. 20, 181-186 (2008).
65. Van Marle, G., Church, D. L., Nunweiler, K. D., Cannon, K., Wainberg, M. A. & Gill, M. J. Higher levels of zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection. Retrovirol 7, 74 (2010).
66. Van Marle, G., Gill, M. J., Kolodka, D., McManus, L., Grant, T. & Church , D. L. Compartmentalization of gut viral reservoir in HIV-1 infected patients. Retrovirol 4, 87 (2007).
67. Sereti, I. et al. Gut mucosa T lymphocyte restoration in chronically HIV+ patients treated with recombinant Interleukin-7. 19th Conference on Retroviruses and Opportunistic Infections (CROI) (abstract no. 19) (2012).